This initial program guidance details the requirements and procedures for implementing the Medicare Drug Price Negotiation Program in 2026, the first year negotiated prices will apply.
The guidance is one of a number of steps CMS laid out in the Medicare Drug Price Negotiation Program timeline for the first year of negotiation. The...National News
Last week, the House passed a Pelosi-backed prescription drug bill that would allow Medicare to negotiate with pharmaceutical companies for lower prices.
If signed into law, H.R.3 would also establish a $2,000/year cap on out of pocket costs for Medicare patients and require drugmakers to pay rebates if their drug prices rise faster...Arizona News
On Monday, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule to lower prescription drug costs for beneficiaries by making changes to Medicare Part D. The proposal could give insurers negotiating powers on drug prices by offering an expectation that plans would implement broader use of prior authorization (PA)...
